--- title: Blog Sen-Jam --- ## [![](https://blog.sen-jam.com/hs-fs/hubfs/sen-jam%20logo-1.png?width=1952&height=522&name=sen-jam%20logo-1.png)](http://www.sen-jam.com) [Follow us on Facebook ](https://www.facebook.com) [Follow us on LinkedIn ](https://www.linkedin.com) [Follow us on Twitter ](https://www.twitter.com) [Follow us on Instagram ](https://www.instagram.com) [✕](https://blog.sen-jam.com#logen-offcanvas-primary) Pioneering the Longevity Revolution #### Sen-Jam Insights TRANSFORMING SYSTEMIC INFLAMMATION ~ THE BIOLOGY BEHIND MOST ALL disease ~ with FIRST-In-CLASS immuno-regulators. [![](https://blog.sen-jam.com/hubfs/beautiful-young-woman-meditating-exercising-top-him.jpg) ](https://blog.sen-jam.com/stories/biggest-problem-inflamation?hsLang=en) [![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) [Sen-Jam](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) 02-06-2026 [News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates?hsLang=en) ### [The Biggest Problem in Modern Medicine: Inflammation](https://blog.sen-jam.com/stories/biggest-problem-inflamation?hsLang=en) [Read More ](https://blog.sen-jam.com/stories/biggest-problem-inflamation?hsLang=en) [![](https://blog.sen-jam.com/hubfs/Screen-Shot-2025-10-02-at-10.46.51-AM-2048x1219.png) ](https://blog.sen-jam.com/stories/european-biopharma-obesity-innovation-forum?hsLang=en) [![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) [Sen-Jam](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) 06-11-2025 [News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates?hsLang=en) ### [Sen-Jam Pharmaceutical Takes the Stage at European Biopharma Obesity Innovation Forum](https://blog.sen-jam.com/stories/european-biopharma-obesity-innovation-forum?hsLang=en) [Read More ](https://blog.sen-jam.com/stories/european-biopharma-obesity-innovation-forum?hsLang=en) [![](https://blog.sen-jam.com/hubfs/skincare.jpg) ](https://blog.sen-jam.com/stories/longevity-global-passion-project-summit?hsLang=en) [![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) [Sen-Jam](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) 04-16-2025 [Longevity & Healthspan](https://blog.sen-jam.com/stories/tag/longevity-healthspan?hsLang=en) ### [The End of Sickcare: From the Inside Out: A Spotlight on Cellular Longevity at the Global Passion Project Summit](https://blog.sen-jam.com/stories/longevity-global-passion-project-summit?hsLang=en) [Read More ](https://blog.sen-jam.com/stories/longevity-global-passion-project-summit?hsLang=en) [![](https://blog.sen-jam.com/hubfs/Screenshot%202026-02-16%20at%206.00.00%20PM.png) ](https://blog.sen-jam.com/stories/executive-leadership-destum-partners?hsLang=en) [![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) [Sen-Jam](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) 03-27-2025 [News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates?hsLang=en) ### [Behind the Breakthrough: Strategic Insights from Sen-Jam's Executive Leadership and Destum Partners](https://blog.sen-jam.com/stories/executive-leadership-destum-partners?hsLang=en) [Read More ](https://blog.sen-jam.com/stories/executive-leadership-destum-partners?hsLang=en) [![](https://blog.sen-jam.com/hubfs/March-IP-Update-KVK-tech-Engineering-Batches.jpg) ](https://blog.sen-jam.com/stories/patent-milestone-stability-data-strengthen-licensing-value-sjp-002c?hsLang=en) [![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) [Sen-Jam](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) 03-23-2025 [News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates?hsLang=en) ### [Patent Milestone and Stability Data Strengthen Licensing Value of SJP-002C](https://blog.sen-jam.com/stories/patent-milestone-stability-data-strengthen-licensing-value-sjp-002c?hsLang=en) [Read More ](https://blog.sen-jam.com/stories/patent-milestone-stability-data-strengthen-licensing-value-sjp-002c?hsLang=en) [![](https://blog.sen-jam.com/hubfs/eid-ashley-lauren-st-john-portrait-1.png) ](https://blog.sen-jam.com/stories/immunology-infectious-disease-dr-ashley-st-john-advisory-board?hsLang=en) [![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) [Sen-Jam](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) 03-11-2025 [News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates?hsLang=en) ### [Sen-Jam Pharmaceutical Welcomes Immunology and Infectious Disease Expert Dr. Ashley St. John to its Scientific Advisory Board](https://blog.sen-jam.com/stories/immunology-infectious-disease-dr-ashley-st-john-advisory-board?hsLang=en) [Read More ](https://blog.sen-jam.com/stories/immunology-infectious-disease-dr-ashley-st-john-advisory-board?hsLang=en) [![](https://blog.sen-jam.com/hubfs/partnerships.jpg) ](https://blog.sen-jam.com/stories/destum-partners-sjp-001-sjp-002c?hsLang=en) [![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) [Sen-Jam](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) 02-10-2025 [News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates?hsLang=en) ### [Sen-Jam Pharmaceutical Engages Destum Partners to Source Strategic Partnerships for SJP-001 & SJP-002C](https://blog.sen-jam.com/stories/destum-partners-sjp-001-sjp-002c?hsLang=en) [Read More ](https://blog.sen-jam.com/stories/destum-partners-sjp-001-sjp-002c?hsLang=en) [![](https://blog.sen-jam.com/hubfs/Toast.png) ](https://blog.sen-jam.com/stories/pharmaceutical-therapeutic-aimed-at-tackling-alcohol-related-risks?hsLang=en) [![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) [Sen-Jam](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) 01-25-2025 [News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates?hsLang=en) ### [Sen-Jam Pharmaceutical Answers Surgeon General's Alarm with a New Therapeutic Aimed at Tackling Alcohol Related Risks](https://blog.sen-jam.com/stories/pharmaceutical-therapeutic-aimed-at-tackling-alcohol-related-risks?hsLang=en) [Read More ](https://blog.sen-jam.com/stories/pharmaceutical-therapeutic-aimed-at-tackling-alcohol-related-risks?hsLang=en) [![](https://blog.sen-jam.com/hubfs/Preliminary-Positive-Results-1-scaled-1.webp) ](https://blog.sen-jam.com/stories/phase-2-clinical-trials-sjp-002c-upper-respiratory-infections-covid-19?hsLang=en) [![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) [Sen-Jam](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) 01-15-2025 [News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates?hsLang=en) ### [Sen-Jam Pharmaceutical Announces Preliminary Results from Phase 2 Clinical Trials of SJP-002C for Upper Respiratory Infections/COVID-19](https://blog.sen-jam.com/stories/phase-2-clinical-trials-sjp-002c-upper-respiratory-infections-covid-19?hsLang=en) [Read More ](https://blog.sen-jam.com/stories/phase-2-clinical-trials-sjp-002c-upper-respiratory-infections-covid-19?hsLang=en) [![](https://blog.sen-jam.com/hubfs/pair-technology-methabolic-balance.jpg) ](https://blog.sen-jam.com/stories/inflammatory-care-pair-technology-metabolic-balance-inflammation-resolution?hsLang=en) [![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) [Sen-Jam](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) 01-14-2025 [News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates?hsLang=en) ### [Sen-Jam Pharmaceutical: Revolutionizing Inflammatory Care with Proprietary PAIR Technology for Metabolic Balance and Inflammation Resolution](https://blog.sen-jam.com/stories/inflammatory-care-pair-technology-metabolic-balance-inflammation-resolution?hsLang=en) [Read More ](https://blog.sen-jam.com/stories/inflammatory-care-pair-technology-metabolic-balance-inflammation-resolution?hsLang=en) [![](https://blog.sen-jam.com/hubfs/pexels-googledeepmind-25626516.jpg) ](https://blog.sen-jam.com/stories/ai-molecule-repurposing?hsLang=en) [![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) [Sen-Jam](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) 01-10-2025 [News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates?hsLang=en) ### [Sen-Jam Pharmaceutical Announces Planned AI Initiative for Repurposed Drug Development](https://blog.sen-jam.com/stories/ai-molecule-repurposing?hsLang=en) [Read More ](https://blog.sen-jam.com/stories/ai-molecule-repurposing?hsLang=en) [![](https://blog.sen-jam.com/hubfs/Hangover%20paper%20Published.jpg) ](https://blog.sen-jam.com/stories/a-global-voice-on-hangover-science-dr.-joris-verster-publishes-new-paper-on-alcohol-inflammation-and-health?hsLang=en) [![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) [Sen-Jam](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) 01-10-2025 ### [New Global Scientific Paper Published on Alcohol Hangover, Inflammation, and Health](https://blog.sen-jam.com/stories/a-global-voice-on-hangover-science-dr.-joris-verster-publishes-new-paper-on-alcohol-inflammation-and-health?hsLang=en) [Read More ](https://blog.sen-jam.com/stories/a-global-voice-on-hangover-science-dr.-joris-verster-publishes-new-paper-on-alcohol-inflammation-and-health?hsLang=en) [![](https://blog.sen-jam.com/hubfs/Screen%20Shot%202026-03-12%20at%202.58.43%20PM.png) ](https://blog.sen-jam.com/stories/sen-jam-pharmaceutical-files-groundbreaking-patent-for-novel-therapeutic-approach-to-address-obesity-and-metabolic-disorders?hsLang=en) [![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) [Sen-Jam](https://blog.sen-jam.com/stories/author/senjam?hsLang=en) 01-09-2025 [News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates?hsLang=en) ### [Sen-Jam Pharmaceutical Files Groundbreaking Patent for Novel Therapeutic Approach to Address Obesity and Metabolic Disorders](https://blog.sen-jam.com/stories/sen-jam-pharmaceutical-files-groundbreaking-patent-for-novel-therapeutic-approach-to-address-obesity-and-metabolic-disorders?hsLang=en) [Read More ](https://blog.sen-jam.com/stories/sen-jam-pharmaceutical-files-groundbreaking-patent-for-novel-therapeutic-approach-to-address-obesity-and-metabolic-disorders?hsLang=en) ### Categories - [News & Company Updates (11)](https://blog.sen-jam.com/stories/tag/news-company-updates?hsLang=en) - [Pipeline & Clinical Insights (10)](https://blog.sen-jam.com/stories/tag/pipeline-clinical-insights?hsLang=en) - [The Biology of Inflammation Resolution (6)](https://blog.sen-jam.com/stories/tag/the-biology-of-inflammation-resolution?hsLang=en) - [Longevity & Healthspan (1)](https://blog.sen-jam.com/stories/tag/longevity-healthspan?hsLang=en)